AbbVie Returns Eye Drug Candidate To Molecular Partners
AbbVie Inc (NYSE: ABBV) has terminated its license and colla
Molecular Partners – Novartis’ COVID-19 Antiviral Shows Encouraging Preclinical Action Against Delta Variant
Molecular Partners AG (NASDAQ:MOLN) reported on the clinical progress of its antiviral candidate, ensovibep, as part of a presentation with…
Novartis Looks To Enter mRNA Technology, Says Chairman: Reuters
Novartis AG (NYSE:NVS) could get into the field of messenger ribonucleic acid (mRNA) technology, reported Reuters, citing Chairman Joerg Reinhardt…